Classic PCOS phenotype is not associated with deficiency of endogenous Vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): A case-control study of lower Silesian women

Gynecological Endocrinology

Volumn 31, Issue 12, 2015, Pages 976-979

  Jedrzejuk, Diana ^a   Łaczmański, Łukasz ^a   Milewicz, Andrzej ^a   Kuliczkowska Płaksej, Justyna ^a   Lenarcik Kabza, Agnieszka ^a   Hirnle, Lidia ^a   Zaleska Dorobisz, Urszula ^a   Lwow, Felicja ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

PCOS; VDR; VDR polymorphism; Vitamin D

Indexed keywords

ANDROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FREE ANDROGEN INDEX; GENE FREQUENCY; GENOTYPE; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; LIPID STORAGE; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POLAND; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; BLOOD; BODY COMPOSITION; COMPLICATION; GENETIC POLYMORPHISM; GENETICS;

ADULT; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; GENOTYPE; HUMANS; PHENOTYPE; POLAND; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SEX HORMONE-BINDING GLOBULIN; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

EID: 84951567970     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1062865     Document Type: Article

References (31)

1. Asunción M, Calvo RM, San Millán JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. JCEM 2000; 85: 2434-8
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800
3. Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: Position statement from European Society of Endocrinology. EJE 2014; 171: 1-29
4. Azziz R. Polycystic ovary syndrome: What's in a name? JCEM 2014; 99: 1142-5
5. Yilmaz M, Isaoglu U, Delibas IB, Kadanali S. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. J Obstet Gynaecol Res 2011; 37: 1020-6
6. Ladrón de Guevara A, Fux-Otta C, Crisosto N, et al. Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations. Fertil Steril 2014; 101: 1732-9
7. Hosseinpanah F, Barzin M, Keihani S, et al. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocr (Oxf) 2014; 81: 93-9
8. Podolski AJ, Brooks ED, Chizen DR, et al. Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: An assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome. Clark Reprod Sci 2014; 21: 1034-43
9. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays 2004; 26: 21-8
10. Muscogiuri G, Mitri J, Mathieu C, et al. Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease. EJE 2014; 171: R101-10
11. Wolden-Kirk H, Gysemans C, Verstuyf A, Mathieu C. Extraskeletal effects of vitamin D. Endocrinol Metab Clin North Am 2012; 41: 571-94
12. Lai YH, Fang TC. The pleiotropic effect of vitamin D. ISRN Nephrol 2013;2013:898125. doi: 10.5402/2013/898125
13. Pitas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D response element in the human insulin receptor gene promoter. JCEM 2007; 92: 2017-19
14. Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the human insulin receptor gene by 1,25-hydroxyvitamin D. Cell Biochem Funct 2002; 20: 227-32
15. Wortsman J, Matsouka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3
16. Kim JJ, Choi YM, Chae SJ, et al. Vitamin D deficiency in women with polycystic ovary syndrome. Clin Reprod Med 2014; 41: 80-5
17. Yildizhan R, Kurdoglu M, Adali E, et al. Serum 25 hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009; 280: 559-63
18. Mahmoudi T, Gourabi H, Ashrafi M, et al. Calcitropic hormones, insulin resistance and the polycystic syndrome. Fertil Steril 2010; 93: 1208-14
19. Hahn S, Haselhorst U, Tan S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 577-83
20. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: A systematic review. Eur J Endocrinol 2012; 166: 765-78
21. Wehr E, Trummer O, Giuliani A., et al. Vitamin D-receptor gene polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. EJE 2011; 164: 741-5
22. Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril 2009; 92: 1381-3
23. Bagheri M, Rad IA, Jazani NH, Nanbakhsh F. Lack of association of vitamin D receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) genetic variations with polycystic ovary syndrome risk: A case control study from Iranian Azeri Turkish women. Maedica (Buchar) 2012; 7: 3033-308
24. Bagheri M, Rad A, Hosseini JN, Nanbakhsh F. Vitamin D receptor TaqI gene variant in exon 9 and polycystic ovary syndrome risk. Int J Fertil Steril 2013; 7: 116-21
25. El-Shal AS, Shalaby SM, Aly NM, et al. Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Mol Biol Reprod 2013; 40: 6063-73
26. Revised 2003 consensus on diagnostic criteria and long-Term health risks related to polycystic ovary syndrome. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril 2004; 81: 19-25
27. Lenarcik-Kabza A, Łaczmanski Ł, Milewicz A, et al. The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome. Endokrynol Pol 2014; 65: 181-8
28. Laczmanski L, Milewicz A, Puzianowska-Kuznicka M, et al. Interrelation between genotypes of the vitamin D receptor gene and serum sex hormone concentrations in the Polish elderly population: The PolSenior study. Exp Gerontol 2014; 57: 188-90
29. Lwow F, Dunajska K, Milewicz A, et al. Effect of moderate-intensity exercise on oxidative stress indices in metabolically healthy obese and metabolically unhealthy obese phenotypes in postmenopausal women: A pilot study. Menopause 2011; 18: 646-53
30. Gallea M, Granazotto M, Azzolini S, et al. Insulin and body weight but not hyperandrogenism seem involved in seasonal serum 25-OH-vitamin D3 levels in subjects affected by PCOS. Gynecol Endocrinol 2014; 13: 1-7
31. Hernandez JL, Olmos JM, Romana G, et al. Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women. J Clin Endocrinol Metab 2014; 99: 3304-9